Agios Pharmaceuticals, Inc. (0HB0.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.57B |
| Enterprise Value | 1.55B |
| P/E Ratio | -4.84 |
| PEG Ratio | 0.03 |
| Price/Sales Ratio | 31.61 |
| Price/Book Ratio | 1.86 |
| Enterprise/Revenue | 30.43 |
| Enterprise/EBITDA | -4.8 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -6.4 |
| Operating Margin | -7.2 |
| Return On Assets | -0.36 |
| Return On Equity | -0.34 |
| Revenue | 54.03M |
| Revenue/Share | 1.12 |
| Gross Profit | 42.51M |
| EBITDA | -466.96M |
| Net Income | -412.78M |
| Diluted EPS | -7.12 |
| Total Cash | 737.04M |
| Total Cash/Share | 12.54 |
| Total Debt | 35.74M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 14.19 |
| Book Value Per Share | 18.87 |
| 52-Week Change | 4.1 |
| 52-Week High | 35.4 |
| 52-Week Low | 20.13 |
| Moving Average 50 Days | 26.18 |
| Moving Average 200 Days | 24.83 |
| Average Volume | 522 |
| Shares Outstanding | 58.18M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |